Document is current
Any future updates will be listed below
-
Authors
Rahmati, Sara
O’Rielly, Darren D.
Li, Quan
Codner, Dianne
Dohey, Amanda
Jenkins, Kari
Jurisica, Igor
Gladman, Dafna D.
Chandran, Vinod
Rahman, Proton
-
Funding
Funding for this research was provided by:
Atlantic Canada Opportunities Agency (781-19095-209843)
Computational Analysis supported by Ontario Research Fund (34876)
Natural Sciences Research Council (NERC #203475)
Canadian Foundation for Innovation (CFI #29272, #225404, #33536)
Buchanan Foundation
IBM Canada
- License Information
-
More Information
Article History
Received: 9 July 2020
Accepted: 1 December 2020
First Online: 10 December 2020
Competing interests
: DG: Grants and/or consulting fees from Abbvie, Amgen, BMS, Eli Lilly, Galapagos, Gilead, Janssen, Novartis, Pfizer, UCB; VC: Advisory board- Abbvie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, UCB; Research grants- Abbvie, Celgene; Spousal employment- Eli Lilly; PR: Advisory board- Abbvie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Merck, Novartis, Pfizer, UCB; Research grants- Janssen, Novartis.
